The FDA has rejected Mesoblast's cell therapy candidate for pediatric acute graft versus host disease, causing the stock to decline. Mesoblast is an old company located in Australia, which may impact ...

I haven’t covered Mesoblast Limited (MESO) in years, my last coverage being on Dec 24, 2020. Interestingly, there have only been two more articles on MESO in the past 30 months. I used to cover MESO a ...

We recently compiled a list of the 10 Best Long Term ASX Stocks to Buy Now. In this article, we are going to take a look at where Mesoblast Limited (NASDAQ:MESO) stands against the other long term ASX ...

We recently compiled a list of the 10 Best ASX Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Mesoblast Limited (NASDAQ:MESO) stands against other best ...